CompletedNCT05400278

Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

Studying Bardet-Biedl syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Oslo University Hospital
Principal Investigator: Charlotte von der Lippe, MD, PhD
Oslo University Hospital
Intervention: No intervention(other)
Enrollment: 30 enrolled
Eligibility: 16-80 years · All sexes
Timeline: 2022 – 2023

Study locations (1)

Oslo University Hospital, Oslo, Norway

Collaborators

Lovisenberg Diakonale Hospital · Sykehuset Telemark

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05400278 on ClinicalTrials.gov

Other trials for Bardet-Biedl syndrome

Additional recruiting or active studies for the same condition.

See all trials for Bardet-Biedl syndrome →

← Back to all trials